[1]
F. Ospina, A. Echeverri, I. Posso-Osorio, L. Jaimes, J. Gutierrez, and G. Tobón, “Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report”, cm, vol. 48, no. 2, pp. 88-93, Jun. 2017.